Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jan;137(1):e20152323.
doi: 10.1542/peds.2015-2323. Epub 2015 Dec 30.

Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections

Jonathan M Wortham  1 , Nellie I Hansen  2 , Stephanie J Schrag  3 , Ellen Hale  4 , Krisa Van Meurs  5 , Pablo J Sánchez  6 , Joseph B Cantey  6 , Roger Faix  7 , Brenda Poindexter  8 , Ronald Goldberg  9 , Matthew Bizzarro  10 , Ivan Frantz  11 , Abhik Das  12 , William E Benitz  5 , Andi L Shane  4 , Rosemary Higgins  13 , Barbara J Stoll  4 ; Eunice Kennedy Shriver NICHD Neonatal Research Network
Collaborators, Affiliations
Multicenter Study

Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections

Jonathan M Wortham et al. Pediatrics. 2016 Jan.

Abstract

Background: Current guidelines for prevention of neonatal group B streptococcal disease recommend diagnostic evaluations and empirical antibiotic therapy for well-appearing, chorioamnionitis-exposed newborns. Some clinicians question these recommendations, citing the decline in early-onset group B streptococcal disease rates since widespread intrapartum antibiotic prophylaxis implementation and potential antibiotic risks. We aimed to determine whether chorioamnionitis-exposed newborns with culture-confirmed, early-onset infections can be asymptomatic at birth.

Methods: Multicenter, prospective surveillance for early-onset neonatal infections was conducted during 2006-2009. Early-onset infection was defined as isolation of a pathogen from blood or cerebrospinal fluid collected ≤ 72 hours after birth. Maternal chorioamnionitis was defined by clinical diagnosis in the medical record or by histologic diagnosis by placental pathology. Hospital records of newborns with early-onset infections born to mothers with chorioamnionitis were reviewed retrospectively to determine symptom onset.

Results: Early-onset infections were diagnosed in 389 of 396,586 live births, including 232 (60%) chorioamnionitis-exposed newborns. Records for 229 were reviewed; 29 (13%) had no documented symptoms within 6 hours of birth, including 21 (9%) who remained asymptomatic at 72 hours. Intrapartum antibiotic prophylaxis exposure did not differ significantly between asymptomatic and symptomatic infants (76% vs 69%; P = .52). Assuming complete guideline implementation, we estimated that 60 to 1400 newborns would receive diagnostic evaluations and antibiotics for each infected asymptomatic newborn, depending on chorioamnionitis prevalence.

Conclusions: Some infants born to mothers with chorioamnionitis may have no signs of sepsis at birth despite having culture-confirmed infections. Implementation of current clinical guidelines may result in early diagnosis, but large numbers of uninfected asymptomatic infants would be treated.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Steps for estimating the number of well-appearing infants born to women with chorioamnionitis potentially treated for each initially asymptomatic infant with culture-confirmed, early-onset infection assuming complete implementation of the Guidelines for Prevention of Perinatal Group B Streptococcal Disease.
FIGURE 2
FIGURE 2
Flow of subject selection from infants with culture-confirmed, early-onset infections identified in the original surveillance study conducted during 2006–2009 at 16 university-based centers of the Neonatal Research Network to inclusion in the present retrospective detailed review of infants with early-onset infections and maternal chorioamnionitis.
See this image and copyright information in PMC

References

    1. Stoll BJ, Hansen NI, Sánchez PJ, et al. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network . Early onset neonatal sepsis: the burden of group B streptococcal and E coli disease continues. Pediatrics. 2011;127(5):817–826 - PMC - PubMed
    1. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937–941 - PMC - PubMed
    1. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD; Active Surveillance Study Group . Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13(7):623–629 - PubMed
    1. Schuchat A. Neonatal group B streptococcal disease—screening and prevention. N Engl J Med. 2000;343(3):209–210 - PubMed
    1. Verani JR, McGee L, Schrag SJ Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36 - PubMed

Publication types